108 related articles for article (PubMed ID: 21317442)
41. Factors associated with common mental disorders and use of psychiatric drugs in cancer outpatients.
Shirama FH; Silva TB; Dos Santos JC; de Oliveira PA; de Oliveira JI; Borges TL; Miasso AI
Arch Psychiatr Nurs; 2019 Oct; 33(5):88-93. PubMed ID: 31711600
[TBL] [Abstract][Full Text] [Related]
42. Psychiatric and physical illness, sociodemographic characteristics, and the use of psychotropic drugs in the community: results from the Upper Bavarian Field Study.
Weyerer S; Dilling H
J Clin Epidemiol; 1991; 44(3):303-11. PubMed ID: 1999690
[TBL] [Abstract][Full Text] [Related]
43. Self-reported use of natural health products: a cross-sectional telephone survey in older Ontarians.
Levine MA; Xu S; Gaebel K; Brazier N; Bédard M; Brazil K; Lohfeld L; MacLeod SM
Am J Geriatr Pharmacother; 2009 Dec; 7(6):383-92. PubMed ID: 20129259
[TBL] [Abstract][Full Text] [Related]
44. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
45. Perceived effectiveness of medications among mental health service users with and without alcohol dependence.
Edlund MJ; Harris KM
Psychiatr Serv; 2006 May; 57(5):692-9. PubMed ID: 16675765
[TBL] [Abstract][Full Text] [Related]
46. National Trends in Psychiatric Not Otherwise Specified (NOS) Diagnosis and Medication Use Among Adults in Outpatient Treatment.
Rajakannan T; Safer DJ; Burcu M; Zito JM
Psychiatr Serv; 2016 Mar; 67(3):289-95. PubMed ID: 26567936
[TBL] [Abstract][Full Text] [Related]
47. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
[TBL] [Abstract][Full Text] [Related]
48. Polypharmacy in psychiatric practice in the Canary Islands.
De las Cuevas C; Sanz EJ
BMC Psychiatry; 2004 Jul; 4():18. PubMed ID: 15236661
[TBL] [Abstract][Full Text] [Related]
49. Mental health professionals' psychotropic pro re nata (p.r.n.) medication practices in acute inpatient mental health care: a qualitative study.
Baker JA; Lovell K; Harris N
Gen Hosp Psychiatry; 2007; 29(2):163-8. PubMed ID: 17336666
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of psychotropic use in a South Australian population.
Goldney R; Bain M
Australas Psychiatry; 2006 Dec; 14(4):379-83. PubMed ID: 17116076
[TBL] [Abstract][Full Text] [Related]
51. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
Radigan M; Lannon P; Roohan P; Gesten F
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
[TBL] [Abstract][Full Text] [Related]
52. Diagnoses associated with the prescription of psychotropic drugs at a Swedish health centre.
Westerling R
Scand J Prim Health Care; 1988 May; 6(2):93-8. PubMed ID: 3387713
[TBL] [Abstract][Full Text] [Related]
53. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
Chen CY; Gerhard T; Winterstein AG
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):187-95. PubMed ID: 19364296
[TBL] [Abstract][Full Text] [Related]
54. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
55. Impact of oil recession on community mental health service utilization in an oil sands mining region in Canada.
Ritchie A; Hrabok M; Igwe O; Omeje J; Ogunsina O; Ambrosano L; Corbett S; Juhás M; Agyapong VI
Int J Soc Psychiatry; 2018 Sep; 64(6):563-569. PubMed ID: 29966476
[TBL] [Abstract][Full Text] [Related]
56. [Factors associated with high exposure to psychotropic drugs in a Montreal catchment epidemiological area].
Perreault M; Djemaâ-Samia MT; Fleury MJ; Touré el H; Mitchell E; Caron J
Sante Ment Que; 2013; 38(1):259-78. PubMed ID: 24337000
[TBL] [Abstract][Full Text] [Related]
57. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
Kanner AM; Gidal BE
Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
[TBL] [Abstract][Full Text] [Related]
58. The prescription of psychotropic drugs in primary health care.
Joukamaa M; Sohlman B; Lehtinen V
Acta Psychiatr Scand; 1995 Nov; 92(5):359-64. PubMed ID: 8619340
[TBL] [Abstract][Full Text] [Related]
59. Psychotropic medication use in children and adolescents in an inpatient setting.
Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
[TBL] [Abstract][Full Text] [Related]
60. Mood and anxiety disorders and the use of services and psychotropic medication in an immigrant population: findings from the Israel National Health Survey.
Ponizovsky AM; Grinshpoon A
Can J Psychiatry; 2009 Jun; 54(6):409-19. PubMed ID: 19527561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
